← All companies

RDHL

RedHill Biopharma Ltd.

RDHL Nasdaq Pharmaceutical Preparations EDGAR ↗

$0.65

+0.02 +3.04%

Key statistics

from XBRL data in SEC filings

Market cap

$33.1B

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

$0.63 – $2.79

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K Jul 28, 2026 6-K Jul 1, 2026 6-K Jun 29, 2026 6-K Jun 25, 2026 6-K Jun 22, 2026 6-K Jun 22, 2026 6-K Jun 22, 2026 6-K Jun 18, 2026 6-K Jun 9, 2026 6-K Jun 8, 2026 6-K Jun 2, 2026 6-K May 27, 2026 6-K Apr 30, 2026 20-F Apr 27, 2026 6-K Apr 27, 2026 6-K Apr 22, 2026 6-K Apr 14, 2026 6-K Mar 5, 2026 6-K Feb 25, 2026 6-K Jan 27, 2026 6-K Jan 22, 2026 6-K Jan 5, 2026 6-K Dec 31, 2025 6-K Dec 23, 2025 6-K Dec 15, 2025 6-K Dec 1, 2025 6-K Nov 26, 2025 6-K Nov 4, 2025 6-K Oct 22, 2025 6-K Oct 21, 2025 6-K Oct 20, 2025 6-K Oct 6, 2025 6-K Sep 29, 2025 6-K/A Sep 5, 2025 6-K Sep 5, 2025 6-K Aug 20, 2025 6-K Aug 18, 2025 6-K Aug 14, 2025 6-K Jul 21, 2025 6-K Jul 1, 2025